Table 2. Main characteristics of cases of West Nile virus infection, EU and EU enlargement countries, 2010–2018 (n = 3,849).
2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2010–2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Demographics | ||||||||||
Median age in years (IQR) | 70 (53–77) |
70 (50–77) |
67 (54–76) |
66 (51–78) |
65 (53–74) |
63 (49–74) |
65 (53–75) |
64 (51–76) |
66 (52–76) |
66 (52–76) |
Female: age (IQR) | 71 (58–78) |
70 (48–77) |
68 (53–77) |
64 (49–79) |
66 (53–75) |
61 (45–69) |
69 (54–77) |
64 (51–76) |
66 (50–77) |
66 (51–77) |
Male: age (IQR) | 67 (50–76) |
70 (52–75) |
66 (54–75) |
67 (53–77) |
64 (52–74) |
63 (51–76) |
64 (52–74) |
64 (50–77) |
66 (54–76) |
66 (53–76) |
Male:female ratio | 1.3 | 1.7 | 1.3 | 1.5 | 1.8 | 2.7 | 1.4 | 1.6 | 1.5 | 1.5 |
Clinical manifestation | ||||||||||
% WNND | 81 | 74 | 68 | 69 | 82 | 78 | 79 | 77 | 70 | 73 |
% WNF | 19 | 25 | 32 | 30 | 18 | 12 | 12 | 16 | 26 | 24 |
% Asymptomatic cases | 0.0 | 0.67 | 0.0 | 0.40 | 0.0 | 10.0 | 8.6 | 7.0 | 4.1 | 3.6 |
Classification | ||||||||||
% Confirmed cases | 50 | 66 | 52 | 73 | 81 | 86 | 89 | 77 | 86 | 78 |
EU: European Union; IQR: interquartile range; WNND: West Nile neuroinvasive disease.